NOAH – AFNET 6

Title

Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes
(NOAH)

This study is partially funded by the German Centre for Cardiovascular Research (DZHK).

Current Status
592 patientes enrolled
150 sites open for recruitment
Status as of 29th June, 2018, updates are carried out quarterly

Number of Patients
2.686

Participating Countries

16 European countries: Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Great Britain, Greece, Italy, Poland, Portugal, Romania, Sweden, Spain, Ukraine

International Chief Investigator

Prof. Paulus Kirchhof, Birmingham, UK / Münster, Germany

Overall Responsibility

Sponsor: Kompetenznetz Vorhofflimmern e.V.  (AFNET e.V.), Münster, Germany 

Flyer for investigators

Publications

Camm AJ, Simantirakis E, Goette A, Lip GY, Vardas P, Calvert M, Chlouverakis G, Diener HC, Kirchhof P. Atrial high-rate episodes and stroke prevention. Europace. 2017 Feb 1;19(2):169-179. doi: 10.1093/europace/euw279.

Kirchhof P, Blank BF, Calvert M, Camm AJ, Chlouverakis G, Diener HC, Goette A, Huening A, Lip GYH, Simantirakis E, Vardas P. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.

Registration

ClinicalTrials.gov: NCT02618577

ISRCTN 17309850

EudraCT number: 2015-003997-33